Mark Tepper

2017

In 2017, Mark Tepper earned a total compensation of $1.3M as President and Chief Scientific Officer at Corbus Pharmaceuticals Holdings, a 23% decrease compared to previous year.

Compensation breakdown

Bonus$164,903
Option Awards$765,210
Salary$349,000
Total$1,279,113

Tepper received $765.2K in option awards, accounting for 60% of the total pay in 2017.

Tepper also received $164.9K in bonus and $349K in salary.

Rankings

In 2017, Mark Tepper's compensation ranked 7,796th out of 14,666 executives tracked by ExecPay. In other words, Tepper earned more than 46.8% of executives.

ClassificationRankingPercentile
All
7,796
out of 14,666
47th
Division
Manufacturing
2,921
out of 5,768
49th
Major group
Chemicals And Allied Products
950
out of 2,074
54th
Industry group
Drugs
737
out of 1,730
57th
Industry
Pharmaceutical Preparations
576
out of 1,329
57th
Source: SEC filing on April 13, 2018.

Tepper's colleagues

We found three more compensation records of executives who worked with Mark Tepper at Corbus Pharmaceuticals Holdings in 2017.

2017

Yuval Cohen

Corbus Pharmaceuticals Holdings

Chief Executive Officer

2017

Barbara White

Corbus Pharmaceuticals Holdings

Chief Medical Officer

2017

Sean Moran

Corbus Pharmaceuticals Holdings

Chief Financial Officer

In-depth

You may also like